This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.

Achieve Life Sciences Adds Two Independent Board Directors

Tipranks - Wed Jun 3, 8:28AM CDT

Claim 55% Off TipRanks

The latest update is out from Achieve Life Sciences ( (ACHV) ).

On May 29, 2026, Achieve Life Sciences, Inc. appointed Jeff Farrow and Reid Waldman, M.D., to its Board of Directors, with Farrow assuming roles on the Nominating and Governance Committee and as Chair of the Audit Committee, and Waldman joining the Commercial Committee and becoming Chair of the Compensation Committee. Both incoming directors will receive pro-rated annual cash retainers, additional committee compensation, and stock options vesting over three years under the company’s non-employee director compensation program, and the company noted there are no special arrangements, family relationships, or related-party transactions associated with their appointments, underscoring standard governance and independence practices.

The most recent analyst rating on (ACHV) stock is a Buy
with a $13.00 price target.
To see the full list of analyst forecasts on Achieve Life Sciences stock,
see the ACHV Stock Forecast page.

Spark’s Take on ACHV Stock

According to Spark, TipRanks’ AI Analyst, ACHV is a Neutral.

Score is held back primarily by weak financial performance (no revenue, sizable losses, and ongoing cash burn with rising leverage). Offsetting this, the latest earnings call conveyed improved funding strength and credible execution plans alongside strong clinical efficacy, while technicals are supportive but appear overextended, and valuation remains constrained by losses.

To see Spark’s full report on ACHV stock,
click here.

More about Achieve Life Sciences

Achieve Life Sciences, Inc. operates in the life sciences and biopharmaceutical sector, focusing on the development and commercialization of therapeutic products. The company is governed by a board of directors that oversees key areas such as audit, governance, compensation, and commercial strategy through specialized committees to support its corporate and operational objectives.

Average Trading Volume: 1,281,167

Technical Sentiment Signal: Hold

Current Market Cap: $537.9M

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.